PROCTER & GAMBLE Co quarterly report, Q1 FY2017

Procter & Gamble Co. — Q1 Fiscal 2017 Form 10-Q Summary

Business Context and Reporting Period

The filing covers the three months ended September 30, 2016, representing the first quarter of fiscal 2017. P&G sells branded consumer packaged goods in more than 180 countries through five continuing reportable segments: Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.

The Beauty Brands and Batteries businesses are reported as discontinued operations. P&G completed the divestiture of 41 Beauty Brands to Coty on October 1, 2016, immediately after the reporting period.

Key Financial Metrics

MetricQ1 FY2017Q1 FY2016Change
Net sales$16.518 billion$16.527 billionFlat
Operating income$3.771 billion$3.768 billionFlat
Operating margin22.8%22.8%Flat
Gross margin51.0%50.7%+30 basis points
Net earnings from continuing operations$2.875 billion$2.777 billion+4%
Net earnings attributable to P&G$2.714 billion$2.601 billion+4%
Diluted EPS from continuing operations$1.00$0.96+4%
Diluted EPS$0.96$0.91+5%
Operating cash flow$3.025 billion$3.538 billion-$513 million
Free cash flow$2.341 billionNot clearly providedNot clearly provided
Free cash flow productivity85%Not clearly providedNot clearly provided

Organic sales increased 3%, organic volume increased 3%, and reported unit volume increased 2%. Foreign exchange reduced reported sales by approximately 3%. Pricing and mix had no net consolidated impact.

The effective tax rate on continuing operations was 23.1%, down 90 basis points. Adoption of new share-based payment accounting guidance produced a discrete tax benefit of $117 million.

Liquidity, Debt and Capital Allocation

  • Cash and cash equivalents were $7.456 billion at September 30, 2016, compared with $7.102 billion at June 30, 2016.
  • Restricted cash was $1.870 billion, primarily related to the Beauty Brands transaction.
  • Available-for-sale investment securities totaled $6.615 billion.
  • Debt due within one year was $12.215 billion; long-term debt was $18.910 billion.
  • Current assets exceeded current liabilities by $2.8 billion; excluding Beauty Brands held-for-sale balances, current liabilities exceeded current assets by $1.2 billion.
  • Capital expenditures were $684 million, or 4.1% of sales.
  • P&G paid $1.851 billion in dividends and repurchased $1.002 billion of treasury stock.
  • Financing activities included $1.519 billion of additional short-term debt, $891 million of long-term debt additions, and $1.001 billion of long-term debt reductions.

Material Changes Versus the Prior Comparable Period

  • Continuing-operations earnings increased despite flat reported sales, primarily due to higher other non-operating income, a lower effective tax rate, and productivity savings.
  • Other non-operating income improved to $63 million from a loss of $18 million, primarily reflecting gains from minor brand divestitures.
  • Gross margin expanded 30 basis points, helped by manufacturing cost savings and volume leverage, but offset by foreign exchange, restructuring, product mix, commodity costs, and initiative investments.
  • SG&A increased 1% and rose to 28.1% of sales, reflecting increased marketing activity partly offset by lower overhead spending.
  • Foreign exchange reduced continuing-operations earnings by approximately $200 million, primarily due to currency weakness in Argentina, Mexico, Egypt, and the United Kingdom.
  • Operating cash flow declined $513 million, reflecting working-capital uses, including increases in accounts receivable and inventories.
  • Discontinued-operations loss improved to $118 million from $142 million, although the current period included $135 million of Beauty Brands transition costs.

Segment Performance

SegmentSalesSales ChangeContinuing-Operations Net EarningsEarnings Change
Beauty$2.996 billion-1%$592 million-5%
Grooming$1.658 billion-1%$415 million+6%
Health Care$1.861 billion+4%$320 million+1%
Fabric & Home Care$5.302 billion+1%$728 million-3%
Baby, Feminine & Family Care$4.595 billion-1%$697 million-7%

Organic sales growth was strongest in Health Care at 7%, followed by Fabric & Home Care at 4%, Beauty and Grooming at 3% each, and Baby, Feminine & Family Care at 2%.

Guidance, Outlook, Risks and Unusual Items

  • The filing does not provide a clear quantitative full-year earnings or sales guidance range.
  • P&G expects approximately $5.5 billion of pretax restructuring costs over fiscal 2012–2017. Approximately 91% had been incurred through September 2016, including $168 million in the quarter.
  • The restructuring program targets approximately $3 billion of annual gross pretax savings; cumulative savings were estimated at approximately $2.5 billion to $3.0 billion.
  • Management expects to support liquidity and operating needs primarily through operating cash flow and debt-market access. P&G announced an expectation to reduce outstanding shares by approximately $15 billion in fiscal 2017 through repurchases and shares exchanged in the Beauty Brands transaction.
  • Key risks include foreign-exchange volatility, economic and political instability, commodity and labor-cost inflation, competitive pricing and promotions, supply-chain disruption, cybersecurity and information-technology dependence, regulatory and tax changes, litigation, and execution of portfolio restructuring and cost-savings initiatives.
  • Shave Care goodwill and related indefinite-lived intangible assets have fair-value cushions below 20% and could be vulnerable to impairment from further currency devaluation or weaker operating performance.
  • P&G has accrued approximately $200 million for uncertain tax positions, interest, and penalties potentially subject to resolution over the next 12 months.
  • Management states that outstanding litigation and environmental contingencies are not expected to materially affect financial position, earnings, or cash flow, although outcomes remain uncertain.

Important Facts for Investors to Verify

  • Completion accounting and cash proceeds from the October 1, 2016 Coty transaction, including the $9.4 billion stock component and assumed $1.9 billion of debt.
  • Post-transaction debt reduction, restricted-cash release, and the effect of the Beauty Brands divestiture on future sales, earnings, margins, and cash flow.
  • Whether organic volume and sales growth can offset foreign-exchange pressure, competitive activity, and pricing-related consumption risks.
  • Progress toward the fiscal 2017 restructuring completion target and the durability of the estimated annual savings.
  • Execution of the planned approximately $15 billion fiscal 2017 share-count reduction and its financing.
  • Exposure to potential impairment in Shave Care and other acquired reporting units.
  • Future cash conversion relative to the company’s long-term free-cash-flow productivity target of at least 90%.